AGT and chronic myelogenous leukemia, BCR-ABL1 positive: In this study, we examined the effect of AGT on four leukemia cell lines and found that it exerted strong antitumor effects, especially on K562, a chronic myelogenous leukemia cell line, and HL60, an acute promyelocytic leukemia cell line.